INS and type 2 diabetes mellitus: Again, the differences between the studies can be explained by methodological differences, since all our patients had type 2 diabetes, the glycemic mean during follow-up was 181.81 ± 46.35 mg/dL, intravenous insulin use in randomization was an exclusion criteria, and platelet function was evaluated after PCI, which by itself may increase platelet reactivity.